Novozymes A/S

BMV:NSIS N Stock Report

Market Cap: Mex$419.7b

Novozymes Past Earnings Performance

Past criteria checks 3/6

Novozymes has been growing earnings at an average annual rate of 1.5%, while the Chemicals industry saw earnings growing at 17.1% annually. Revenues have been growing at an average rate of 5.4% per year. Novozymes's return on equity is 21.2%, and it has net margins of 16.9%.

Key information

1.53%

Earnings growth rate

2.51%

EPS growth rate

Chemicals Industry Growth13.08%
Revenue growth rate5.40%
Return on equity21.18%
Net Margin16.89%
Next Earnings Update03 May 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Novozymes makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

BMV:NSIS N Revenue, expenses and earnings (DKK Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 2317,8993,0243,3252,017
30 Sep 2317,8253,2093,2912,013
30 Jun 2317,7363,4253,3192,027
31 Mar 2317,8053,6283,2842,010
31 Dec 2217,5533,6763,1981,986
30 Sep 2216,8583,4183,2921,951
30 Jun 2216,2523,1083,1081,911
31 Mar 2215,5463,0932,9951,912
31 Dec 2114,9513,1462,8281,982
30 Sep 2114,5633,1752,4921,995
30 Jun 2114,2333,0442,3972,037
31 Mar 2114,0022,8952,3082,008
31 Dec 2014,0122,8252,2991,905
30 Sep 2014,2973,0932,3031,850
30 Jun 2014,5703,0202,4311,893
31 Mar 2014,6793,2732,4971,968
31 Dec 1914,3743,1542,4591,966
30 Sep 1914,3573,0692,4921,959
30 Jun 1914,3113,2382,3981,939
31 Mar 1914,3513,1162,3511,859
31 Dec 1814,3903,2262,3341,852
30 Sep 1814,3493,1832,3221,897
30 Jun 1814,2713,1942,3081,837
31 Mar 1814,3113,1542,3821,849
31 Dec 1714,5313,1192,4701,901
30 Sep 1714,5723,1312,4861,895
30 Jun 1714,3823,0632,4681,887
31 Mar 1714,2733,0772,4391,866
31 Dec 1614,1423,0502,4141,865
30 Sep 1613,8802,9362,4341,841
30 Jun 1614,0122,9292,4771,880
31 Mar 1614,0322,8612,4641,931
31 Dec 1514,0022,8232,4621,896
30 Sep 1513,7312,7342,3901,906
30 Jun 1513,3932,6302,3421,878
31 Mar 1513,0052,5392,3241,812
31 Dec 1412,4592,5262,2761,766
30 Sep 1412,2182,4842,3381,688
30 Jun 1411,9702,4132,3111,614
31 Mar 1411,9342,3792,3321,577
31 Dec 1311,7462,2002,3211,528
30 Sep 1311,6172,1322,2531,533
30 Jun 1311,5192,0852,2831,536

Quality Earnings: NSIS N has high quality earnings.

Growing Profit Margin: NSIS N's current net profit margins (16.9%) are lower than last year (20.9%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: NSIS N's earnings have grown by 1.5% per year over the past 5 years.

Accelerating Growth: NSIS N's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: NSIS N had negative earnings growth (-17.7%) over the past year, making it difficult to compare to the Chemicals industry average (-35.1%).

Return on Equity

High ROE: NSIS N's Return on Equity (21.2%) is considered high.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/04/10 05:17
End of Day Share Price 2024/01/12 00:00
Earnings2023/12/31
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Novozymes A/S is covered by 28 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Alexander SloaneBarclays
Cezara LozneanuBarclays
Sebastian SatzBarclays